Both in Pharmaceuticals
Propanc Biopharma vs PMGC Holdings
Over the past year PPCB returned −99.3% and ELAB returned −99.9%; their daily moves had a correlation of 0.04.
PPCB −99.3% ELAB −99.9%Growth of $1, one year, split-adjusted
| Metric | PPCB | ELAB |
|---|---|---|
| Price | $1.79 | $1.92 |
| Market cap | $1.8M | $1.6M |
| Today | +4.68% | −1.03% |
| 1 month | −63.6% | −41.3% |
| 6 months | −92.9% | −91.0% |
| Year to date | −98.7% | −99.5% |
| 1 year | −99.4% | −99.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 29.5% |
| Net margin | — | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.6× |
| Net cash | $832.0K | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 730.0% | 677.7% |
| Short % of float | 0.7% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).